EIKO LIFESCIENCES share price
BSE: 540204Chemicals & PetrochemicalsSmall Cap
Last close ₹50.79up ₹1.68 (3.42%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹49.11.
52-week range of traded prices to 23 Oct 2026
₹43.00Low, 15 Sep 2026₹64.44High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹74 Cr3,149th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.07
- Volume, BSEVolume. Shares traded on the last trading day.
- 21,594
Results
Standalone, as consolidated accounts are on record for only 5 of the last ten years; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 12 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹14 Crdown 10.85%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.06 Crdown 5.30%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 7.5%
Revenue by year
Peak revenue ₹42 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 11 Nov | Dec 2024Filed 13 Feb | Mar 2025Filed 12 Jun | Jun 2025Filed 29 Jul | Sep 2025Filed 31 Oct | Dec 2025Filed 29 Jan | Mar 2026Filed 26 May | Jun 2026Filed 12 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.7 | 6.9 | 7.1 | 7.5 | 9.2 | 9.6 | 15.9 | 14.2 |
| Net profit | 0.2 | 0.3 | 0.9 | 0.7 | 0.8 | 0.9 | 1.1 | 1.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.7% | 4.1% | 12.7% | 9.3% | 8.9% | 9.9% | 7.1% | 7.5% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Specialty & Fine ChemicalsSpecialty & Fine Chemicals, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹46.0 Cr87.3%
- Logistics ServicesLogistics Services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹6.7 Crup 63.51%12.7%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Not shown, P/E: a results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 8% of 1,207 trading days over the last 5 years.
LowestHighest
Its median1.5Industry median2.5
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.8.3
At or below today's level on 5% of 1,207 trading days over the last 5 years.
LowestHighest
Its median39.2Industry median16.2
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −4.9% | +97.4% | −51.8% | 0.0% |
| 3 years | −13.3% | +39.3% | −37.8% | 0.0% |
| 5 years | −8.9% | +9.2% | −16.6% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth over 1 year includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the year to Mar 2025.
Peers and competitors
Specialty Chemicals, 130 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to EIKO LIFESCIENCES in market cap.
EIKO LIFESCIENCES is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Deep PolymersDEEP | 90 | 7.2 | 0.9 | 7.7 | +7.8% | +146.9% | 12.9% | 5.4% | 0.00% |
 Deepak ChemtexDEEPAKCHEM | 89 | 5.3 | 1.4 | – | −14.9% | +35.4% | 28.6% | – | 0.00% |
 Alkali MetalsALKALI | 79 | 31.0 | 1.8 | 14.7 | +13.7% | – | 6.0% | 6.2% | 1.28% |
 Renol PolychemRNPL | 78 | 9.4 | 0.7 | – | – | – | 7.6% | – | 0.00% |
 Technichem OrganicsTECHNICHEM | 73 | 26.9 | 1.5 | – | −0.4% | −32.4% | 5.8% | – | 0.00% |
 Shlokka DyesSHLOKKA | 73 | 14.7 | 0.9 | – | – | – | 5.8% | – | 0.00% |
 Indian EmulsifiersIEML | 71 | 4.4 | 0.5 | 4.6 | +57.9% | +22.3% | 14.2% | 11.5% | 0.00% |
 Kkalpana Industries (India)KKALPANAIND | 58 | 77.0 | 1.6 | – | −17.9% | +59.7% | 2.1% | −23.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹0.25 a share, year to Mar 2017.
| Ex-date | Type | Per share |
|---|---|---|
| 20 Sep 2017 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.25 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
16 Oct · Announcement under Regulation 30 (LODR)-Allotment
Sep 2026
Aug 2026
27 Aug · Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('The Listing Regulations')
EIKO LIFESCIENCES share price by year
Each calendar year to 2025.EIKO LIFESCIENCES share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 55.05 | −12.3% | 64.80 | 45.34 |
| 2024 | 62.74 | −2.1% | 78.43 | 47.05 |
| 2023 | 64.06 | +31.3% | 100.00 | 51.20 |
| 2022 | 48.80 | −33.1% | 73.10 | 37.10 |
| 2021 | 72.90 | +114.4% | 105.00 | 34.00 |
| 2020 | 34.00 | +120.1% | 40.50 | 7.66 |
| 2019 | 15.45 | −77.9% | 70.00 | 15.45 |
| 2018 | 70.00 | +169.7% | 72.75 | 27.00 |
| 2017 | 25.95 | +20.9% | 29.10 | 19.85 |
| 2016 | 21.46 | – | 21.46 | 12.28 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2016 is from its first session, 13 Dec 2016. The 2018 close is its last trade, on 5 Nov 2018.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 49.98 | 53.00 | 47.00 | 50.79 | 49.91 | 21,594 |
| 22 Oct 2026 | 49.00 | 50.00 | 46.86 | 49.11 | 49.11 | 36,081 |
| 21 Oct 2026 | 51.99 | 51.99 | 48.43 | 49.02 | 48.71 | 7,910 |
| 19 Oct 2026 | 49.00 | 53.00 | 48.76 | 51.14 | 50.61 | 16,968 |
| 16 Oct 2026 | 49.50 | 49.50 | 48.99 | 49.00 | 49.02 | 526 |
| 15 Oct 2026 | 49.50 | 49.50 | 48.42 | 49.18 | 49.17 | 1,766 |
| 14 Oct 2026 | 49.09 | 49.09 | 47.36 | 48.89 | 48.48 | 3,159 |
| 13 Oct 2026 | 48.98 | 48.98 | 48.20 | 48.85 | 48.77 | 3,736 |
| 12 Oct 2026 | 47.59 | 48.69 | 46.85 | 47.54 | 47.59 | 3,751 |
| 9 Oct 2026 | 46.65 | 48.00 | 46.25 | 46.65 | 47.51 | 4,187 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 7 Jul 2023 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.
Company details
- Legal name
- EIKO LIFESCIENCES LIMITED
- BSE code
- 540204
- ISIN
- INE666Q01016
- Industry
- Chemicals & Petrochemicals
- Listed
- Dec 2016
- Face value
- ₹10
- CIN
- L65993MH1977PLC258134
- Corporate identity number, the registrar of companies' code for it